A 22-year-old cisgender woman was diagnosed with HIV in her first trimester of pregnancy and started on bictegravir-tenofovir alafenamide-emtricitabine. She intermittently took antiretroviral medication during the third trimester and had an HIV RNA level of 16,480 copies/mL 2 weeks before delivery. She received intrapartum intravenous zidovudine and had an uncomplicated cesarean delivery.
Which one of the following would you recommend regarding oral antiretroviral management of the newborn?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
June 7th, 2024
June 7th, 2024
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5